z-logo
open-access-imgOpen Access
A rare case report of tuberculous uveitis
Author(s) -
Jayashree S Shah,
Indireddy Prathyusha
Publication year - 2019
Publication title -
journal of medical research
Language(s) - English
Resource type - Journals
ISSN - 2395-7565
DOI - 10.31254/jmr.2019.5102
Subject(s) - medicine , uveitis , tuberculosis , blinding , incidence (geometry) , dermatology , surgery , disease , toxoplasmosis , ocular tuberculosis , pediatrics , ophthalmology , pathology , randomized controlled trial , physics , optics
Background: Uveitis is a broad range of disease processes that involves the uveal tract and its associated ocular structures. Tuberculosis was leading causes of uveitis in the past but the incidence has reduced with the improved antibiotic therapy. Recently, incidence of ocular involvement due to tuberculosis has again been raising. Tuberculous uveitis can be readily treatable and if not diagnosed early can be vision threatening with irreversible blindness for the patient. In this study we are reporting a rare case of refractory uveitis, responding to anti-tuberculous therapy inspite of being no positive investigations in favour of tuberculosis. Case presentation: A 48 years immunocompetent male had reported to ophthalmology opd with diminision of vision in both eyes since 2 months which was of painless and progressive type. Patient is a known diabetic since 2 years and is on regular treatment. Patient was initially diagnosed as TORCH related uveitis and treated for the same. There was initial response to treatment, following which patient developed relapse within 1 month duration. Later, Tuberculosis being one of the most common causative agents of uveitis, patient has been emperically started on ATT, following which there is resolution of lesions. Conclusion: It is essential to know the varied range of ocular manifestations of tuberculosis as there is no specific test to confirm the diagnosis. Early recognition and timely management prevents the severe blinding complications in these patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here